Home/Filings/8-K/0001104659-26-004122
8-K//Current report

ZYNEX INC 8-K

Accession 0001104659-26-004122

$ZYXIQCIK 0000846475operating

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 4:35 PM ET

Size

237.0 KB

Accession

0001104659-26-004122

Research Summary

AI-generated summary of this filing

Updated

Zynex Inc. Files Chapter 11 Plan, Amends $22.3M DIP Credit Facility

What Happened
Zynex, Inc. (ZYXIQ) confirmed its Chapter 11 bankruptcy proceedings (Case No. 25-90810) in the U.S. Bankruptcy Court for the Southern District of Texas. The company filed a Combined Disclosure Statement and Joint Plan of Reorganization on January 14, 2026 (Docket No. 175) consistent with a Restructuring Support Agreement dated December 15, 2025. On that same day Zynex entered into a First Amendment to its senior secured debtor‑in‑possession (DIP) credit agreement to extend certain milestones related to final DIP approval, bidding procedures and approval of compensation plans.

Key Details

  • Chapter 11 petition date: December 15, 2025; cases jointly administered as In re Zynex, Inc., et al., Case No. 25-90810.
  • DIP Facility: $22.3 million delayed‑draw senior secured debtor‑in‑possession term loan (initial draw $10.15M, second draw $5.0M, third draw $7.15M). Original DIP credit agreement entered Dec. 17, 2025 after interim DIP order.
  • First Amendment to DIP Credit Agreement dated January 14, 2026 extends certain milestone deadlines tied to the final DIP order, bidding procedures order and approval of compensation plans. Amendment is filed as Exhibit 10.1 to the 8‑K.
  • The Plan provides for a sale process and a contemplated equity transaction with a Plan Sponsor; any Excess Sale Proceeds will be distributed under the Plan. Court filings and case materials are available at https://dm.epiq11.com/Zynex.

Why It Matters
The filings confirm Zynex is operating under a court‑supervised Chapter 11 restructuring with a committed DIP financing facility providing up to $22.3M of liquidity on a delayed‑draw schedule. The disclosed Plan contemplates a sale process and an equity transaction with a Plan Sponsor, which are material to creditors and equity holders because they determine how claims and any residual value will be allocated. Investors should monitor court approvals, the outcome of the sale process, and any disclosure about the Plan Sponsor and finalized terms, since those steps will affect capitalization, creditor recoveries and potential impacts on existing equity.